Efficacy of Targeted Immunotherapy as Induction or Salvage Therapy in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.

Ben PonvilawanPongthep VittayawacharinPattaraporn TunsingWeerapat Owattanapanich

Published in: Technology in cancer research & treatment (2021)

The ALL patients receiving CD-targeted immunotherapy as induction or salvage therapy had significantly higher response rates and survival outcomes, as well as lower odds of acquiring febrile neutropenia, than the patients given conventional chemotherapy.

Keyphrases

acute lymphoblastic leukemia
end stage renal disease
ejection fraction
newly diagnosed
cancer therapy
chronic kidney disease
chemotherapy induced
prognostic factors
stem cells
patient reported outcomes
locally advanced
acute myeloid leukemia